BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Orexigen Therapeutics, Inc. 

48 Wall Street
Suite 1100
New York  New York  10005  U.S.A.
Phone: 212-918-4650 Fax: 212-918-4801


SEARCH JOBS


Industry
Biotechnology






 Company News
Orexigen Therapeutics, Inc. (OREX) Reports Corporate And Financial Results For The Fourth Quarter And Year Ended December 31, 2013 3/13/2014 6:12:17 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Host Full Year And Fourth Quarter 2013 Financial Results Conference Call And Webcast 3/3/2014 7:07:22 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At The 34th Annual Cowen and Company Health Care Conference 2/27/2014 6:57:41 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At Upcoming Investor Conferences 2/6/2014 6:47:05 AM    More...
Orexigen Therapeutics, Inc. (OREX) Announces June 10, 2014 PDUFA Action Date For Contrave 1/7/2014 6:48:04 AM    More...
Orexigen Therapeutics, Inc. (OREX) To Present At The J.P. Morgan 2014 Healthcare Conference 1/7/2014 6:20:58 AM    More...
Orexigen Therapeutics, Inc. (OREX) Resubmits Contrave New Drug Application 12/11/2013 9:53:38 AM    More...
Orexigen Therapeutics, Inc. (OREX) Announces The Closing Of Its Offering Of $115 Million Of Convertible Senior Notes 12/6/2013 9:30:29 AM    More...
Orexigen Therapeutics, Inc. (OREX) Prices Offering Of $100 Million Of Convertible Senior Notes 12/3/2013 11:29:44 AM    More...
Orexigen Therapeutics, Inc. (OREX) Offers $100 Million Of Convertible Senior Notes 12/3/2013 7:21:05 AM    More...
12345678910...

//-->